Showing results (41-50 of 4,509) with videos related to

Sort By:
Pageof 451
Future Oncology (London, England)|April 13, 2022
Plain language summary of results from the JAVELIN Bladder 100 study: avelumab maintenance treatment for advanced urothelial cancerThomas Powles, Se Hoon Park, Eric Voog, et al.
Future Oncology (London, England)|July 19, 2022
T cell-inflamed gene expression profile and PD-L1 expression and pembrolizumab efficacy in advanced esophageal cancerManish A Shah, Takashi Kojima, Daniel Hochhauser, et al.
Future Oncology (London, England)|July 20, 2022
Obinutuzumab in the treatment of B-cell malignancies: a comprehensive reviewAndrew Davies, Arnon P Kater, Jeff P Sharman, et al.
Future Oncology (London, England)|August 31, 2010
Assessment and significance of quality of life in women with gynecologic cancerDana M Chase, Tawny Watanabe, Bradley J Monk
Future Oncology (London, England)|October 6, 2010
Sunitinib for metastatic renal cell carcinomaDeborah Mukherji, James Larkin, Lisa Pickering
Future Oncology (London, England)|October 6, 2010
Germline genetic markers for urinary bladder cancer risk, prognosis and treatment responseAnne J Grotenhuis, Sita H Vermeulen, Lambertus A Kiemeney
Future Oncology (London, England)|October 6, 2010
The potential of immunomodulatory drugs in the treatment of solid tumorsAngus Dalgleish, Christine Galustian
Future Oncology (London, England)|October 6, 2010
Role of cell cycle perturbations in the combination therapy of chemotherapeutic agents and radiationBea Pauwels, An Wouters, Marc Peeters, et al.
Future Oncology (London, England)|October 6, 2010
Intramedullary spinal cord metastases in breast cancer are associated with improved longer-term systemic controlAdrian Zebrowski, Louise Wilson, Adrian Lim, et al.
Future Oncology (London, England)|November 11, 2010
ASA404: a tumor vascular-disrupting agent with broad potential for cancer therapyBruce C Baguley, Mark J McKeage
Pageof 451